CN106975028A - 一种治疗痛风的中药制剂的制备方法 - Google Patents
一种治疗痛风的中药制剂的制备方法 Download PDFInfo
- Publication number
- CN106975028A CN106975028A CN201710103932.2A CN201710103932A CN106975028A CN 106975028 A CN106975028 A CN 106975028A CN 201710103932 A CN201710103932 A CN 201710103932A CN 106975028 A CN106975028 A CN 106975028A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- chinese medicine
- gout
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 69
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 201000005569 Gout Diseases 0.000 title claims abstract description 34
- 239000000463 material Substances 0.000 claims abstract description 30
- 235000009508 confectionery Nutrition 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 71
- 239000006071 cream Substances 0.000 claims description 31
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 28
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 28
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 28
- 229920002472 Starch Polymers 0.000 claims description 26
- 239000002245 particle Substances 0.000 claims description 26
- 239000008107 starch Substances 0.000 claims description 26
- 235000019698 starch Nutrition 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000005913 Maltodextrin Substances 0.000 claims description 24
- 229920002774 Maltodextrin Polymers 0.000 claims description 24
- 229940035034 maltodextrin Drugs 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 22
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 21
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 21
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 21
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 21
- 238000005469 granulation Methods 0.000 claims description 20
- 230000003179 granulation Effects 0.000 claims description 20
- 229920002261 Corn starch Polymers 0.000 claims description 18
- 239000008120 corn starch Substances 0.000 claims description 18
- 229940099112 cornstarch Drugs 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 17
- 235000003599 food sweetener Nutrition 0.000 claims description 17
- 239000003765 sweetening agent Substances 0.000 claims description 17
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 14
- 229930195725 Mannitol Natural products 0.000 claims description 14
- 239000000594 mannitol Substances 0.000 claims description 14
- 235000010355 mannitol Nutrition 0.000 claims description 14
- 239000011812 mixed powder Substances 0.000 claims description 14
- 239000006188 syrup Substances 0.000 claims description 14
- 235000020357 syrup Nutrition 0.000 claims description 14
- 108010011485 Aspartame Proteins 0.000 claims description 11
- 239000000605 aspartame Substances 0.000 claims description 11
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 11
- 235000010357 aspartame Nutrition 0.000 claims description 11
- 229960003438 aspartame Drugs 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 240000002900 Arthrospira platensis Species 0.000 claims description 9
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 9
- 244000189799 Asimina triloba Species 0.000 claims description 9
- 235000006264 Asimina triloba Nutrition 0.000 claims description 9
- 244000025254 Cannabis sativa Species 0.000 claims description 9
- 235000009467 Carica papaya Nutrition 0.000 claims description 9
- 244000077995 Coix lacryma jobi Species 0.000 claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 9
- 244000111489 Gardenia augusta Species 0.000 claims description 9
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 9
- 241001474977 Palla Species 0.000 claims description 9
- 244000197580 Poria cocos Species 0.000 claims description 9
- 235000008599 Poria cocos Nutrition 0.000 claims description 9
- 244000046146 Pueraria lobata Species 0.000 claims description 9
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 9
- 241000271897 Viperidae Species 0.000 claims description 9
- 229940082787 spirulina Drugs 0.000 claims description 9
- 229960001855 mannitol Drugs 0.000 claims description 8
- 238000004064 recycling Methods 0.000 claims description 8
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims description 7
- 239000004377 Alitame Substances 0.000 claims description 7
- 241000218236 Cannabis Species 0.000 claims description 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 7
- 239000004384 Neotame Substances 0.000 claims description 7
- 235000019409 alitame Nutrition 0.000 claims description 7
- 108010009985 alitame Proteins 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 239000008101 lactose Substances 0.000 claims description 7
- 229930189775 mogroside Natural products 0.000 claims description 7
- 235000019412 neotame Nutrition 0.000 claims description 7
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 7
- 108010070257 neotame Proteins 0.000 claims description 7
- 239000011122 softwood Substances 0.000 claims description 7
- 235000020985 whole grains Nutrition 0.000 claims description 7
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 6
- 229940013618 stevioside Drugs 0.000 claims description 6
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 6
- 235000019202 steviosides Nutrition 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000005461 lubrication Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 20
- 239000000243 solution Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 241001092040 Crataegus Species 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000003085 diluting agent Substances 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000013112 stability test Methods 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- -1 sorbierite Substances 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000005434 MCC/mannitol excipient Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000003625 trehaloses Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种治疗痛风的中药制剂的制备方法,该制备方法通过调整辅料的种类以及用量,解决了临床应用上中药类压片糖果口感不良及其易吸湿受潮导致退色等质量不稳定问题,从而使产品稳定性更好。本发明方法简便,生产成本低,产品质量稳定,口感润滑、甜度适宜,患者容易接受。
Description
技术领域
本发明属于药品、保健食品、食品领域,涉及一种组合物制剂的制备方法,特别是涉及一种治疗痛风的中药制剂的制备方法。
背景技术
随着人们生活水平的提高,饮食结构的变化,糖、脂肪、蛋白质摄入量明显增加,痛风的发病率有逐年增高的趋势,除了侵犯骨和关节,还容易累及肾脏和心血管***,高尿酸血症及原发性痛风与肥胖症、高脂血症、高血压病、糖尿病、动脉粥样硬化等疾病呈显著正相关。从临床实践来看,多数痛风病人不仅血尿酸值增高,而且血脂值也较高。在这种情况下,使用不良反应较少的保健食品、中药或中西药配合使用治疗痛风,有一定的优势,尤其是使用“药食同源”的原料制成的药品、保健品以及食品,更符合人们对疾病的治疗、日常保健的需求。
压片糖果其特点主要是通过口腔颊面粘膜吸收,具有吸收快、起效迅速等特点,在药学上可分为中药类和西药类。与西药类的化学制剂相比,中药类口服制剂常因口感不良以及易吸湿受潮导致质量问题在临床应用上受到极大制约,服用时与口腔接触时间更长的压片糖果尤为如此。而目前已有的中药类压片糖果往往存在易吸湿受潮导致退色等质量问题,同时由于添加大量的蔗糖来改善其口感,限制了糖尿病患者的使用。
发明内容
本发明针对现有中药类压片糖果口感不良、易吸湿受潮导致退色等质量不稳定以及为了改善其口感而使用大量蔗糖等问题,提供一种治疗痛风的中药制剂的制备方法,解决了临床应用上中药类压片糖果口感不良、易吸湿受潮导致退色等问题,从而使产品稳定性更好,患者更容易接受。本发明制剂简便,质量稳定,口感香甜滑口,不含蔗糖,可长期用于治疗痛风疾病,尤其适合伴随高血糖的患者使用,同时兼具提高机体免疫力的作用。
为解决上述技术问题,本发明是通过以下技术方案实现的:
一种治疗痛风的中药制剂的制备方法,包括如下步骤:
处方:药材提取清膏130-250份、玉米淀粉30-40份、麦芽糊精100-200份、微晶纤维素10-50份、甘露醇10-50份、甜味剂1-10份及占以上所述组分总重量0.5-1.0%的海藻糖;
制备方法:
(1)分别取:麦芽糊精、微晶纤维素、甘露醇,粉碎,过100目筛,备用;
(2)按配方量称取玉米淀粉、海藻糖,加水100份使溶解成淀粉海藻糖浆;
(3)按配方量称取步骤(1)项下各辅料,以等量递增法混合均匀,得混合粉;
(4)取步骤(3)项下的混合粉,按配方量加入药材提取清膏和步骤(3)项下的淀粉海藻糖浆制软材,过筛制粒,干燥,控制水分在2%以内,过筛整粒,得颗粒;
(5)按配方量称取甜味剂,与步骤(5)项下颗粒混合均匀,压片,即得。
以上所述治疗痛风的中药制剂的制备方法,所述处方进一步优选为:药材提取清膏150-200份、玉米淀粉30-40份、麦芽糊精150-200份、微晶纤维素10-30份、甘露醇10-30份、甜味剂3-8份及占以上所述组分总重量0.5-0.8%的海藻糖。
以上所述治疗痛风的中药制剂的制备方法,所述处方最佳优选为:药材提取清膏180份、玉米淀粉30份、麦芽糊精150份、微晶纤维素30份、甘露醇30份、甜味剂5份及占以上所述组分总重量0.7%的海藻糖。
以上所述治疗痛风的中药制剂的制备方法,所述药材提取清膏的制备方法优选为:按以下重量份称取:葛根100-200份、仙草80-150份、蝮蛇10-30份、山楂80-150份、木瓜80-150份、火麻仁80-150份、栀子80-150份、茯苓50-100份、螺旋藻50-100份、薏苡仁50-100份,加6-8倍量水,煎煮提取2次,每次1-2小时,煎液过滤,合并滤液,加1-2倍量乙醇,混匀,静置过夜,滤过,滤液回收乙醇至无醇味并浓缩至相对密度在60℃时为1.25.-1.28的清膏。
以上所述治疗痛风的中药制剂的制备方法,所述药材提取清膏的制备方法最佳优选为:按以下重量份称取:葛根150份、仙草100份、蝮蛇20份、山楂100份、木瓜100份、火麻仁100份、栀子100份、茯苓80份、螺旋藻80份、薏苡仁80份,加水煎煮提取2次,每次1小时,第一次加8倍量的水,第二次加6倍量的水,煎液过滤,合并滤液,加1.5倍量乙醇,混匀,静置过夜,滤过,滤液回收乙醇至无醇味并浓缩至相对密度在60℃时为1.26的清膏。
以上所述治疗痛风的中药制剂的制备方法,所述甜味剂优选为低聚果糖或乳糖与甜菊糖、阿司巴甜、纽甜、罗汉果甜苷、阿力甜中的一种组合,最佳优选为低聚果糖与阿司巴甜。
进一步的,步骤(4)项下所述过筛步骤所用的筛网优选为20-40目,最佳优选为30目;步骤(5)项下所述干燥步骤温度优选为60-70℃。
本发明的有益效果是:
1.本发明克服现有中药类压片糖果口感不良及其易吸湿受潮导致退色等质量不稳定问题,使产品稳定性更好,疗效更确切,适用于痛风患者长期服用,无副作用。
2.本发明制剂简便,颗粒流动性好,压片不粘冲,所制得的片剂表面光滑,不易吸湿受潮,口感香甜滑口,质量稳定,携带方便,尤其适用于老年人和不能吞咽固体制剂的患者,生物利用度高,使用更安全有效。
3.本发明不含蔗糖,适合糖尿病患者服用,还可以补充人体所需的营养、提高免疫力,提高痛风患者的生活质量。
具体实施方式
虽然本说明书通过特别指出并清楚要求保护本发明的权利要求书作出结论,但应该相信下列说明将更好地理解本发明。
如本文所用,单词“优选”及变体是指在特定环境下能够提供特定有益效果的本发明的实施方案。然而,其它的实施方案在相同或其它的环境下也可以是优选的。此外,一个或多个优选实施方案的详述并不表示其它实施方案是无用的,并且不旨在从本发明的范畴排除其它的实施方案。
一、制剂条件筛选
1.粘合剂选择
粘合剂能使粉粒润湿,呈现粘性,以利于制备颗粒,压成片剂。本发明对比了干法压片、湿法制粒再压片,干法压片采用普通压片机效果不好,对设备要求高,故本发明采用湿法制粒再压片。试验中对比了5%羟丙甲纤维素水溶液、20%麦芽糊精、30%淀粉浆、85%乙醇做粘合剂,结果见表1。
表1粘合剂考察结果表
序号 | 粘合剂 | 制粒情况 | 颗粒外观 |
1 | 5%羟丙甲纤维素水溶液 | 成团,制粒易结块 | 颗粒硬 |
2 | 20%麦芽糊精 | 少量成团,制粒易结块 | 颗粒较硬 |
3 | 30%淀粉浆 | 成团,制粒不结块 | 颗粒松紧合适 |
4 | 80%乙醇 | 不成团,制粒不结块 | 颗粒松 |
从表1中的试验结果可知:本发明使用30%淀粉浆制粒情况效果较好,故本发明粘合剂选择蔗糖溶液。为进一步优化淀粉溶液浓度,本发明继续优化淀粉溶液浓度,试验结果见表2。
表2淀粉溶液浓度考察结果表
序号 | 湿润剂 | 制粒情况 | 颗粒外观 |
1 | 20%淀粉溶液 | 不成团,制粒困难 | 颗粒松 |
2 | 30%淀粉溶液 | 成团,制粒不结块 | 颗粒松紧合适 |
3 | 40%淀粉溶液 | 成团,制粒不结块 | 颗粒松紧合适 |
4 | 50%淀粉溶液 | 成团,制粒结块 | 颗粒紧 |
从表2中的试验结果可知:本发明使用30%-40%淀粉溶液制粒情况效果较好,浓度低太松,浓度高太紧,均影响制粒,故本发明粘合剂选择30%-40%淀粉溶液。
2.稀释剂的选择
易吸湿受潮是中药类口服固体制剂尤其是压片糖果普遍存在的问题,因此在稀释剂的种类和用量的筛选时要尽量能降低其吸潮性。基于生产成本的考虑,本发明试验中对比了麦芽糊精、微晶纤维素与甘露醇、山梨醇、木糖醇组合使用时的压片情况、片剂硬度、口感,并将分别用上述稀释剂制成的样品,分别用聚乙烯瓶装好,置稳定性加速试验箱内试验:温度:40±2℃,相对湿度:75±5%,加速试验3个月,试验结果见表3。
表3稀释剂试验结果表
从表3中的试验结果可知:麦芽糊精、微晶纤维素与甘露醇、山梨醇或木糖醇组合用作稀释剂时,压片情况均良好,片剂硬度适中,口感均较好,但加速试验发现,麦芽糊精、微晶纤维素与山梨醇或木糖醇组合使用为稀释剂制成的样品,水分含量变化大,不符合规定,故本发明选用麦芽糊精、微晶纤维素、甘露醇为稀释剂。
3.甜味剂的选择
只有具有良好口感的压片糖果才易被人们接受,因此,较于普通片剂来说,压片糖果的口感较为重要,而此往往通过甜味剂的选择来实现。本发明试验中对比了海藻糖、低聚果糖、乳糖、葡萄糖、甜菊糖、阿司巴甜、罗汉果甜苷、纽甜、阿力甜等甜味剂的使用,以口感、外观性状、水分含量为考察指标,并将分别用上述甜味剂制成的样品,分别用聚乙烯瓶装好,置稳定性加速试验箱内试验:温度:40±2℃,相对湿度:75±5%,加速试验3个月,结果见表4。
表4甜味剂试验结果表
表4的试验结果表明:海藻糖与低聚果糖或乳糖组合,再配以阿司巴甜组合使用时,口感均较好,加速试验3个月外观性状、水份变化均不大,说明海藻糖能使本发明产品稳定性更好,故本发明选用海藻糖、低聚果糖、乳糖、阿司巴甜为甜味剂。为此,进一步考察海藻糖的加入量并将所得样品进行加速试验,试验方法同表4,结果详见表5。
表5海藻糖的加入量试验结果表
从表5中的试验结果可知:加入0.2-0.4%海藻糖后压片糖果的外观性状、水分含量变化均较大;而含0.5-1.5%海藻糖的压片糖果的外面性状、水分含量在3个月的加速时间内变化小,质量稳定,出于生产成本的考虑,本发明控制海藻糖的加入量为0.5-1.0%。
本发明还进一步对比了海藻糖、低聚果糖与阿司巴甜、甜菊糖、纽甜、罗汉果甜苷、阿力甜中的一种组合使用时的口感,结果口感均较好,其中以海藻糖、低聚果糖与阿司巴甜组合为甜味剂时口感最佳,故本发明选用海藻糖与低聚果糖、乳糖中的一种组合,再配以阿司巴甜、甜菊糖、纽甜、罗汉果甜苷、阿力甜中的一种为甜味剂。
二、治疗痛风的中药制剂的制备方法
实施例1
治疗痛风的中药制剂的制备方法,包括如下步骤:
处方:药材提取清膏180kg、玉米淀粉30kg、麦芽糊精150kg、微晶纤维素30kg、甘露醇30kg、低聚果糖4.5kg、阿司巴甜0.5kg及占以上所述组分总重量0.7%的海藻糖2.954kg;
制备方法:
(1)按以下重量份称取:葛根150kg、仙草100kg、蝮蛇20kg、山楂100kg、木瓜100kg、火麻仁100kg、栀子100kg、茯苓80kg、螺旋藻80kg、薏苡仁80kg,加水煎煮提取2次,每次1小时,第一次加8倍量的水,第二次加6倍量的水,煎液过滤,合并滤液,加1.5倍量乙醇,混匀,静置过夜,滤过,滤液回收乙醇至无醇味并浓缩至相对密度在60℃时为1.26的清膏;
(2)分别取:麦芽糊精、微晶纤维素、甘露醇,粉碎,过100目筛,备用;
(3)按配方量称取玉米淀粉、海藻糖,加水100升使溶解成淀粉海藻糖浆;
(4)按配方量称取步骤(2)项下各辅料,以等量递增法混合均匀,得混合粉;
(5)取步骤(4)项下的混合粉,按配方量加入步骤(1)项下的药材提取清膏和步骤(3)项下的淀粉海藻糖浆制软材,过30目筛制粒,65℃干燥,控制水分在2%以内,过筛30目整粒,得颗粒;
(6)按配方量称取低聚果糖、阿司巴甜,与步骤(5)项下颗粒混合均匀,压片,即得。
实施例2
治疗痛风的中药制剂的制备方法,包括如下步骤:
处方:药材提取清膏130kg、玉米淀粉30kg、麦芽糊精100kg、微晶纤维素10kg、甘露醇10kg、乳糖0.5kg、甜菊糖0.5kg及占以上所述组分总重量0.5%的海藻糖1.405kg;
制备方法:
(1)按以下重量份称取:葛根100kg、仙草80kg、蝮蛇10kg、山楂80kg、木瓜80kg、火麻仁80kg、栀子80kg、茯苓50kg、螺旋藻50kg、薏苡仁80kg,分别加6倍量的水煎煮提取2次,第一次2小时,第二次1小时,煎液过滤,合并滤液,加1倍量乙醇,混匀,静置过夜,滤过,滤液回收乙醇至无醇味并浓缩至相对密度在60℃时为1.25的清膏;
(2)分别取:麦芽糊精、微晶纤维素、甘露醇,粉碎,过100目筛,备用;
(3)按配方量称取玉米淀粉、海藻糖,加水100升使溶解成淀粉海藻糖浆;
(4)按配方量称取步骤(2)项下各辅料,以等量递增法混合均匀,得混合粉;
(5)取步骤(4)项下的混合粉,按配方量加入步骤(1)项下的药材提取清膏和步骤(3)项下的淀粉海藻糖浆制软材,过40目筛制粒,70℃干燥,控制水分在2%以内,过筛40目整粒,得颗粒;
(6)按配方量称取低聚果糖、阿司巴甜,与步骤(5)项下颗粒混合均匀,压片,即得。
实施例3
治疗痛风的中药制剂的制备方法,包括如下步骤:
处方:药材提取清膏250kg、玉米淀粉40kg、麦芽糊精200kg、微晶纤维素50kg、甘露醇50kg、低聚果糖9.5kg、罗汉果甜苷1kg及占以上所述组分总重量1.0%的海藻糖6kg;
制备方法:
(1)按以下重量份称取:葛根200kg、仙草150kg、蝮蛇30kg、山楂150kg、木瓜150kg、火麻仁150kg、栀子150kg、茯苓100kg、螺旋藻100kg、薏苡仁100kg,分别加8倍量的水煎煮提取2次,每次2小时,煎液过滤,合并滤液,加2倍量乙醇,混匀,静置过夜,滤过,滤液回收乙醇至无醇味并浓缩至相对密度在60℃时为1.28的清膏;
(2)分别取:麦芽糊精、微晶纤维素、甘露醇,粉碎,过100目筛,备用;
(3)按配方量称取玉米淀粉、海藻糖,加水100升使溶解成淀粉海藻糖浆;
(4)按配方量称取步骤(2)项下各辅料,以等量递增法混合均匀,得混合粉;
(5)取步骤(4)项下的混合粉,按配方量加入步骤(1)项下的药材提取清膏和步骤(3)项下的淀粉海藻糖浆制软材,过20目筛制粒,60℃干燥,控制水分在2%以内,过筛20目整粒,得颗粒;
(6)按配方量称取低聚果糖、罗汉果甜苷,与步骤(5)项下颗粒混合均匀,压片,即得。
实施例4
治疗痛风的中药制剂的制备方法,包括如下步骤:
处方:药材提取清膏200kg、玉米淀粉35kg、麦芽糊精180kg、微晶纤维素40kg、甘露醇40kg、低聚果糖7kg、纽甜1kg及占以上所述组分总重量0.8%的海藻糖4.024kg;
制备方法:
(1)按以下重量份称取:葛根180kg、仙草120kg、蝮蛇25kg、山楂120kg、木瓜120kg、火麻仁120kg、栀子120kg、茯苓70kg、螺旋藻70kg、薏苡仁70kg,加水煎煮提取2次,每次1小时,第一次加8倍量的水,第二次加6倍量的水,煎液过滤,合并滤液,加1.5倍量乙醇,混匀,静置过夜,滤过,滤液回收乙醇至无醇味并浓缩至相对密度在60℃时为1.27的清膏;
(2)分别取:麦芽糊精、微晶纤维素、甘露醇,粉碎,过100目筛,备用;
(3)按配方量称取玉米淀粉、海藻糖,加水100升使溶解成淀粉海藻糖浆;
(4)按配方量称取步骤(2)项下各辅料,以等量递增法混合均匀,得混合粉;
(5)取步骤(4)项下的混合粉,按配方量加入步骤(1)项下的药材提取清膏和步骤(3)项下的淀粉海藻糖浆制软材,过30目筛制粒,62℃干燥,控制水分在2%以内,过筛30目整粒,得颗粒;
(6)按配方量称取低聚果糖、纽甜,与步骤(5)项下颗粒混合均匀,压片,即得。
实施例5
治疗痛风的中药制剂的制备方法,包括如下步骤:
处方:药材提取清膏150kg、玉米淀粉30kg、麦芽糊精130kg、微晶纤维素20kg、甘露醇20kg、低聚果糖2.5kg、阿力甜0.5kg及占以上所述组分总重量0.6%的海藻糖2.118kg;
制备方法:
(1)按以下重量份称取:葛根120kg、仙草90kg、蝮蛇15kg、山楂90kg、木瓜90kg、火麻仁90kg、栀子90kg、茯苓60kg、螺旋藻60kg、薏苡仁60kg,加水煎煮提取2次,每次1小时,第一次加8倍量的水,第二次加6倍量的水,煎液过滤,合并滤液,加1.5倍量乙醇,混匀,静置过夜,滤过,滤液回收乙醇至无醇味并浓缩至相对密度在60℃时为1.26的清膏;
(2)分别取:麦芽糊精、微晶纤维素、甘露醇,粉碎,过100目筛,备用;
(3)按配方量称取玉米淀粉、海藻糖,加水100升使溶解成淀粉海藻糖浆;
(4)按配方量称取步骤(2)项下各辅料,以等量递增法混合均匀,得混合粉;
(5)取步骤(4)项下的混合粉,按配方量加入步骤(1)项下的药材提取清膏和步骤(3)项下的淀粉海藻糖浆制软材,过30目筛制粒,68℃干燥,控制水分在2%以内,过筛30目整粒,得颗粒;
(6)按配方量称取低聚果糖、阿力甜,与步骤(5)项下颗粒混合均匀,压片,即得。
三、稳定性试验
将上述实施例1-5样品分别用聚乙烯瓶装好,置稳定性加速试验箱内试验:温度:40±2℃,相对湿度:75±5%,加速试验3个月,结果实施例1-5样品的外观性状、口感、水分等稳定性重点考察指标与0时样品测定结果比较,均无明显变化,说明本发明实施例1-5样品质量较为稳定,可满足贮存、运输、使用的稳定性要求。试验结果见表6。
表6治疗痛风的中药制剂稳定性试验结果表
。
Claims (10)
1.一种治疗痛风的中药制剂的制备方法,其特征在于,包括如下步骤:
处方:药材提取清膏130-250份、玉米淀粉30-40份、麦芽糊精100-200份、微晶纤维素10-50份、甘露醇10-50份、甜味剂1-10份及占以上所述组分总重量0.5-1.0%的海藻糖;
制备方法:
(1)分别取:麦芽糊精、微晶纤维素、甘露醇,粉碎,过100目筛,备用;
(2)按配方量称取玉米淀粉、海藻糖,加水100份使溶解成淀粉海藻糖浆;
(3)按配方量称取步骤(1)项下各辅料,以等量递增法混合均匀,得混合粉;
(4)取步骤(3)项下的混合粉,按配方量加入药材提取清膏和步骤(3)项下的淀粉海藻糖浆制软材,过筛制粒,干燥,控制水分在2%以内,过筛整粒,得颗粒;
(5)按配方量称取甜味剂,与步骤(5)项下颗粒混合均匀,压片,即得。
2.根据权利要求1所述治疗痛风的中药制剂的制备方法,其特征在于,所述处方为:药材提取清膏150-200份、玉米淀粉30-40份、麦芽糊精150-200份、微晶纤维素10-30份、甘露醇10-30份、甜味剂3-8份及占以上所述组分总重量0.5-0.8%的海藻糖。
3.根据权利要求1所述治疗痛风的中药制剂的制备方法,其特征在于,所述处方为:药材提取清膏180份、玉米淀粉30份、麦芽糊精150份、微晶纤维素30份、甘露醇30份、甜味剂5份及占以上所述组分总重量0.7%的海藻糖。
4.根据权利要求1-3中任一所述治疗痛风的中药制剂的制备方法,其特征在于,所述药材提取清膏的制备方法为:按以下重量份称取:葛根100-200份、仙草80-150份、蝮蛇10-30份、山楂80-150份、木瓜80-150份、火麻仁80-150份、栀子80-150份、茯苓50-100份、螺旋藻50-100份、薏苡仁50-100份,加6-8倍量水,煎煮提取2次,每次1-2小时,煎液过滤,合并滤液,加1-2倍量乙醇,混匀,静置过夜,滤过,滤液回收乙醇至无醇味并浓缩至相对密度在60℃时为1.25.-1.28的清膏。
5.根据权利要求1-3中任一所述治疗痛风的中药制剂的制备方法,其特征在于,所述药材提取清膏的制备方法为:按以下重量份称取:葛根150份、仙草100份、蝮蛇20份、山楂100份、木瓜100份、火麻仁100份、栀子100份、茯苓80份、螺旋藻80份、薏苡仁80份,加水煎煮提取2次,每次1小时,第一次加8倍量的水,第二次加6倍量的水,煎液过滤,合并滤液,加1.5倍量乙醇,混匀,静置过夜,滤过,滤液回收乙醇至无醇味并浓缩至相对密度在60℃时为1.26的清膏。
6.根据权利要求1-3中任一所述治疗痛风的中药制剂的制备方法,其特征在于,所述甜味剂为低聚果糖或乳糖与甜菊糖、阿司巴甜、纽甜、罗汉果甜苷、阿力甜中的一种组合。
7.根据权利要求1-3中任一所述治疗痛风的中药制剂的制备方法,其特征在于,所述甜味剂为低聚果糖与阿司巴甜。
8.根据权利要求1所述治疗痛风的中药制剂的制备方法,其特征在于,步骤(4)项下所述过筛步骤所用的筛网为20-40目。
9.根据权利要求1所述治疗痛风的中药制剂的制备方法,其特征在于,步骤(4)项下所述过筛步骤所用的筛网为30目。
10.根据权利要求1所述治疗痛风的中药制剂的制备方法,其特征在于,步骤(4)项下所述干燥步骤温度为60-70℃。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710103932.2A CN106975028A (zh) | 2017-02-24 | 2017-02-24 | 一种治疗痛风的中药制剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710103932.2A CN106975028A (zh) | 2017-02-24 | 2017-02-24 | 一种治疗痛风的中药制剂的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106975028A true CN106975028A (zh) | 2017-07-25 |
Family
ID=59338646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710103932.2A Pending CN106975028A (zh) | 2017-02-24 | 2017-02-24 | 一种治疗痛风的中药制剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106975028A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110313599A (zh) * | 2018-03-30 | 2019-10-11 | 广州溯原生物科技有限公司 | 一种降尿酸果冻及其制备方法 |
CN114652798A (zh) * | 2022-03-22 | 2022-06-24 | 珠海市木棉网络科技有限公司 | 一种具有治疗痛风效果的压片糖果制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103622019A (zh) * | 2013-12-02 | 2014-03-12 | 广西健丰药业有限公司 | 一种降血脂、降尿酸中药组合物 |
-
2017
- 2017-02-24 CN CN201710103932.2A patent/CN106975028A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103622019A (zh) * | 2013-12-02 | 2014-03-12 | 广西健丰药业有限公司 | 一种降血脂、降尿酸中药组合物 |
Non-Patent Citations (1)
Title |
---|
姜锡瑞等: "《生物发酵产业技术》", 31 May 2016, 中国轻工业出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110313599A (zh) * | 2018-03-30 | 2019-10-11 | 广州溯原生物科技有限公司 | 一种降尿酸果冻及其制备方法 |
CN114652798A (zh) * | 2022-03-22 | 2022-06-24 | 珠海市木棉网络科技有限公司 | 一种具有治疗痛风效果的压片糖果制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019101804A4 (en) | Traditional Chinese medicine medical nutrition therapy-based composition for treating diabetes, and application | |
CN104146197A (zh) | 一种小儿健胃消食果冻粉及其制备方法 | |
CN104126790A (zh) | 一种痰湿体质保健食品及其制备方法 | |
CN108112973A (zh) | 一种辅助降三高组合物及其制备方法 | |
CN107828588A (zh) | 一种糯米酒及其制备工艺 | |
CN111195314A (zh) | 一种养胃消食中药组合物及其制备方法 | |
CN106723015A (zh) | 一种具有抗疲劳和抗氧化功能的保健食品及其制备工艺 | |
CN101007071A (zh) | 治疗急、慢性肠、胃炎及细菌性痢疾的中药及其制备工艺 | |
CN106975028A (zh) | 一种治疗痛风的中药制剂的制备方法 | |
KR102150162B1 (ko) | 인체 흡수형 진세노사이드가 증진된 활성산양삼 추출액을 포함하는 스틱형 용기용 액상 조성물 및 그 제조방법 | |
CN104473025A (zh) | 一种山麦冬养阴生津汤圆及其生产方法 | |
CN103550398A (zh) | 一种缓解疲劳的组合物及其制备方法和医药用途 | |
CN106667937B (zh) | 一种黑枸杞多糖咀嚼片 | |
CN105767967A (zh) | 一种火龙果果皮糕及其制备方法 | |
CN105920394A (zh) | 一种水果味小儿清肺化痰凝胶剂及其制备方法 | |
CN115944667A (zh) | 一种苓桂术甘汤提取物及其制备方法 | |
CN104922469A (zh) | 铁皮石斛保健果汁及其制备方法 | |
CN106581115A (zh) | 含芫根和人参的组合物及其应用 | |
CN106309809B (zh) | 一种清心神安颗粒及其制备方法 | |
CN107961293A (zh) | 一种沙棘番茄片及其制备方法 | |
CN107456495A (zh) | 一种用于咳嗽、痰多、气喘的组合物颗粒剂及其制备方法 | |
CN103719863B (zh) | 一种高丽红参咀嚼片的制备方法 | |
CN102485263B (zh) | 一种治疗小儿久咳的药物组合物及制备方法 | |
CN114304355A (zh) | 一种辅助降血糖的压片糖果及其制备方法 | |
CN101473937B (zh) | 一种红茶保健食品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170725 |